Literature DB >> 6074152

Human brucellosis: an evaluation of antibiotics in the treatment of brucellosis.

J Rizzo-Naudi, N Griscti-Soler, W Ganado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 6074152      PMCID： PMC2466178          DOI： 10.1136/pgmj.43.502.520

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  10 in total

1.  AMPICILLIN IN TREATMENT OF SALMONELLA TYPHI CARRIERS AND BRUCELLA MELITENSIS SEPTICAEMIA.

Authors:  Z FARID; S BASSILY; M S OMAR
Journal:  Lancet       Date:  1964-10-03       Impact factor: 79.321

Review 2.  BRUCELLOSIS.

Authors:  P W BOTHWELL
Journal:  Practitioner       Date:  1963-11

3.  TREATMENT OF BRUCELLOSIS BY NALIDIXIC ACID.

Authors:  B SHARMA
Journal:  Lancet       Date:  1965-05-29       Impact factor: 79.321

4.  Teeth pigmented by tetracycline.

Authors:  I S WALLMAN; H B HILTON
Journal:  Lancet       Date:  1962-04-21       Impact factor: 79.321

5.  Treatment of undulant fever.

Authors:  Z FARID; M S OMAR; A MIALE; A S PRASAD
Journal:  Lancet       Date:  1963-02-09       Impact factor: 79.321

6.  Current status of therapy of brucellosis in human beings.

Authors:  W W SPINK
Journal:  J Am Med Assoc       Date:  1960-02-13

7.  Exanthem in brucellosis treated with novobiocin.

Authors:  A AZNAR REIG; A LOPEZ
Journal:  Lancet       Date:  1959-11-28       Impact factor: 79.321

8.  Treatment of undulant fever.

Authors:  J T GOST
Journal:  Lancet       Date:  1958-01-25       Impact factor: 79.321

9.  Tetracyclines and the teeth.

Authors:  J Weyman
Journal:  Practitioner       Date:  1965-11

10.  Human Brucellosis--some clinical observations.

Authors:  W Ganado
Journal:  Scott Med J       Date:  1965-12       Impact factor: 0.729
  10 in total
  6 in total

1.  Functional characterization of Brucella melitensis NorMI, an efflux pump belonging to the multidrug and toxic compound extrusion family.

Authors:  Martine Braibant; Laurence Guilloteau; Michel S Zygmunt
Journal:  Antimicrob Agents Chemother       Date:  2002-09       Impact factor: 5.191

2.  Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Authors:  J D Colmenero; L C Fernández-Gallardo; J A Agúndez; J Sedeño; J Benítez; E Valverde
Journal:  Antimicrob Agents Chemother       Date:  1994-12       Impact factor: 5.191

3.  Ampicillin in the treatment of brucellosis. A controlled therapeutic trial.

Authors:  D G McDevitt
Journal:  Br J Ind Med       Date:  1970-01

4.  Sensitivity of Brucella spp to tetracycline and its analogues.

Authors:  I D Farrell; P M Hinchliffe; L Robertson
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

5.  Relevance of in vitro antimicrobial susceptibility of Brucella melitensis to relapse rate in human brucellosis.

Authors:  J Ariza; J Bosch; F Gudiol; J Liñares; P F Viladrich; R Martín
Journal:  Antimicrob Agents Chemother       Date:  1986-12       Impact factor: 5.191

Review 6.  The legacy of haemophilia: Memories and reflections from three survivors.

Authors:  Albert Farrugia; Cees Smit; Andrea Buzzi
Journal:  Haemophilia       Date:  2022-05-19       Impact factor: 4.263
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.